LobbyingLurie Children's Hospital of Chicago lobbying by quarter
Lurie Children's Hospital of Chicago's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Lurie Children's Hospital of Chicago
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 1 |
| Q1 2023 | $80K | 1 |
| Q2 2023 | $260K | 1 |
| Q3 2023 | $180K | 1 |
| Q4 2023 | $120K | 1 |
| Q1 2024 | $80K | 1 |
| Q2 2024 | $60K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $60K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$760K · 15 reports
- Budget and appropriations$580K · 12 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $1.3M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JORDAN BROSSI | Staff Assist., Leg. Corr., Sen. Tammy Baldwin; Leg. Corr., Sen. Joe Manchin; LA, Rep. Susie Lee; Health LA, Health Policy Advisor, Rep. Anna Eshoo | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/10for Q2 | Holland & Knight | $60K |
| 04/05for Q1 | Holland & Knight | $60K |
| 01/11for Q4 2025 | Holland & Knight | $60K |
| 25/10/18for Q3 2025 | Holland & Knight | $60K |
| 25/07/15for Q2 2025 | Holland & Knight | $60K |
| 25/04/11for Q1 2025 | Holland & Knight | $60K |
| 25/01/11for Q4 2024 | Holland & Knight | $60K |
| 24/10/02for Q3 2024 | Holland & Knight | $40K |
| 24/07/05for Q2 2024 | Holland & Knight | $60K |
| 24/04/22for Q1 2024 | Holland & Knight | $80K |
| 24/01/22for Q4 2023 | Holland & Knight | $120K |
| 23/10/19for Q3 2023 | Holland & Knight | $180K |
| 23/07/19for Q2 2023 | Holland & Knight | $260K |
| 23/04/19for Q1 2023 | Holland & Knight | $80K |
| 23/04/19for Q1 2023 | Holland & Knight | $80K |
| 23/01/19for Q4 2022 | Holland & Knight | $100K |